Levemir Sales Data

Rank 30 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Levemir U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 30 9.34% 0.86%
Q3 2013 30 (4) 6.54% -4.34%
Q2 2013 34 (6) 8.40% 4.69%
Q1 2013 40 8.81% 4.92%
Q4 2012 40 (9) 12.31% 7.91%
Q3 2012 49 (8) 7.66% 4.30%
Q2 2012 57 (11) 6.58% 3.02%
Q1 2012 68 (7) 9.25% 8.69%
Q4 2011 75 (1) 8.66% 5.02%
Q3 2011 76 (1) 1.83% 4.10%
Q2 2011 75 (5) -0.11% 23.65%
Q1 2011 80

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
August 27, 2009FDA Warns About Stolen Insulin
November 13, 2008Novo Nordisk Launches Levemir Satisfaction Guarantee Program
Hide
(web5)